Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Fusion Pharmaceuticals Inc (FUSN)

Fusion Pharmaceuticals Inc (FUSN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Acquisition of Fusion Pharmaceuticals Completed Newswire.ca - Tue Jun 4, 3:05PM CDT

/CNW/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs), announced...

FUSN : 21.55 (+0.14%)
Fusion Pharmaceuticals Receives Final Court Order Approving Arrangement Newswire.ca - Fri May 31, 3:05PM CDT

/CNW/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs) as precision...

FUSN : 21.55 (+0.14%)
Fusion Pharmaceuticals Shareholders Approve Acquisition by AstraZeneca Newswire.ca - Wed May 29, 3:05PM CDT

/CNW/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs) as precision...

FUSN : 21.55 (+0.14%)
Fusion Pharmaceuticals Announces First Patient Dosed in the Phase 2 Portion of the AlphaBreak Trial Evaluating FPI-2265 in Metastatic Castration-Resistant Prostate Cancer Newswire.ca - Thu May 9, 3:14PM CDT

/CNW/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs) as precision...

FUSN : 21.55 (+0.14%)
Fusion Pharmaceuticals Reports First Quarter 2024 Financial Results and Announces Clinical Program Updates Newswire.ca - Tue May 7, 6:00AM CDT

/CNW/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs) as precision...

FUSN : 21.55 (+0.14%)
Fusion Pharmaceuticals Mails Circular for Special Meeting of Shareholders and Announces Receipt of Interim Order Newswire.ca - Thu Apr 25, 3:34PM CDT

/CNW/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radioconjucates (RCs) as precision...

FUSN : 21.55 (+0.14%)
Fusion Pharmaceuticals Announces Presentation of Interim Data from the Phase 2 TATCIST Clinical Trial Evaluating FPI-2265 at the AACR Annual Meeting 2024 Newswire.ca - Tue Apr 9, 3:05PM CDT

/CNW/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs) as precision...

FUSN : 21.55 (+0.14%)
Healthcare - iStock-1346675584
Next-Gen Cancer Therapies Could Spark Upside for AstraZeneca Stock Barchart - Tue Mar 26, 3:27PM CDT

Next-generation cancer therapies are here. AstraZeneca - already an oncology leader - is going down the path of radiopharmaceuticals with its purchase of Fusion. Along with the other potential blockbuster...

AZN : 64.26 (+1.68%)
FUSN : 21.55 (+0.14%)
NVS : 103.85 (+0.74%)
LLY : 749.92 (-0.46%)
BMY : 58.23 (+0.60%)
Fusion Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Clinical Program Updates Newswire.ca - Wed Mar 20, 3:05PM CDT

/CNW/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision...

FUSN : 21.55 (+0.14%)
Wall Street - NY Stock Exchange -mHdATQY9fIU-unsplash
Stocks Recover on Lower Bond Yields and Strength in Energy Stocks Barchart - Tue Mar 19, 3:33PM CDT

The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.56%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.83%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.26%. Stocks on Tuesday...

$SPX : 5,948.71 (+0.53%)
SPY : 593.67 (+0.54%)
$DOWI : 43,870.35 (+1.06%)
DIA : 438.97 (+1.08%)
$IUXX : 20,740.78 (+0.36%)
QQQ : 504.98 (+0.36%)
^BTCUSD : 98,369.78 (+0.40%)
ZNZ24 : 109-185 (+0.07%)
IP : 59.18 (+0.58%)
FUSN : 21.55 (+0.14%)
BKR : 44.88 (+1.29%)
APA : 22.44 (+1.40%)

Barchart Exclusives

Up 882% YTD, Is It Too Late to Buy This Fintech Stock? Barchart - 27 minutes ago
A recent guidance boost from DAVE propelled the stock even higher. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot